Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.
Schwöppe C, Zerbst C, Fröhlich M, Schliemann C, Kessler T, Liersch R, Overkamp L, Holtmeier R, Stypmann J, Dreiling A, König S, Höltke C, Lücke M, Müller-Tidow C, Mesters RM, Berdel WE.
Schwöppe C, et al. Among authors: kessler t.
J Med Chem. 2013 Mar 28;56(6):2337-47. doi: 10.1021/jm301669z. Epub 2013 Mar 15.
J Med Chem. 2013.
PMID: 23496322